BioLargo Common Stock

The latest common stock for BLGO is $220K as of June 2026. That compares with $210K in the prior-year period — up 5.9% year over year. Investors often review this figure alongside BioLargo's historical trend and sector peers before judging valuation or financial health.

Over the past year, BLGO's common stock moved from $210K to $220K — a 5.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in BioLargo's operating scale or balance-sheet position.

A common stock figure of $220K for BLGO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BLGO's common stock ($220K), review year-over-year change from $210K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.